Martin A. Graham
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Dermatology top 5%
- Co-authors
- Dennis GreensladeG. LockwoodÉrick GamelinS. BrienzaM. BayssasMary Ann MascelliDaniel E. EverittYaowei Zhu
- Topics
- Cancer Treatment and Pharmacology (7 papers)Cancer therapeutics and mechanisms (7 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
- Cited by
- OncologyImmunologyDermatology
- Journals
- Journal of Clinical OncologyClinical Cancer ResearchJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Martin A. Graham
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Oncology 540
- Immunology 390
- Molecular Biology 278
- Pathology and Forensic Medicine 183
- Dermatology 148
Countries citing papers authored by Martin A. Graham
This map shows the geographic impact of Martin A. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin A. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin A. Graham more than expected).
Fields of papers citing papers by Martin A. Graham
This network shows the impact of papers produced by Martin A. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin A. Graham. The network helps show where Martin A. Graham may publish in the future.
Co-authorship network of co-authors of Martin A. Graham
This figure shows the co-authorship network connecting the top 25 collaborators of Martin A. Graham. A scholar is included among the top collaborators of Martin A. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin A. Graham. Martin A. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 13 | |
| 3 | 60 | |
| 4 | 82 | |
| 5 | 56 | |
| 6 | A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis. | 17 |
| 7 | 107 | |
| 8 | 212 | |
| 9 | 1 | |
| 10 | 95 | |
| 11 | 55 | |
| 12 | 94 | |
| 13 | Phase I pharmacokinetic study of the novel antitumor agent SR233377. | 17 |
| 14 | 25 | |
| 15 | 30 | |
| 16 | 7 | |
| 17 | 27 | |
| 18 | 6 | |
| 19 | Phase I and pharmacokinetic study of rhizoxin. | 25 |
| 20 | 4 |
About Martin A. Graham
Martin A. Graham is a scholar working on Pharmacology, Transplantation and Oncology, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (540 citations), Immunology (390 citations) and Dermatology (148 citations). Martin A. Graham has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Dennis Greenslade, G. Lockwood, Érick Gamelin, S. Brienza, M. Bayssas, Mary Ann Mascelli, Daniel E. Everitt, Yaowei Zhu, Eiko Toichi and Charles Pendley. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.